financetom
Business
financetom
/
Business
/
Celestica Insider Sold Shares Worth $53,965,221, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Celestica Insider Sold Shares Worth $53,965,221, According to a Recent SEC Filing
Feb 6, 2025 12:41 AM

03:25 AM EST, 02/06/2025 (MT Newswires) -- Robert Mionis, Chief Executive Officer, on February 05, 2025, sold 441,325 shares in Celestica ( CLS ) for $53,965,221. Following the Form 4 filing with the SEC, Mionis has control over a total of 531,417 common shares of the company, with 531,417 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1030894/000095017025014743/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Mar 23, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Market Chatter: Takeda, Eli Lilly to Face Class Action Over Actos Cancer Risk
Market Chatter: Takeda, Eli Lilly to Face Class Action Over Actos Cancer Risk
Mar 23, 2026
10:58 AM EDT, 03/23/2026 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) and Eli Lilly ( LLY ) will face a multibillion-dollar class action accusing them of concealing diabetes drug Actos' bladder cancer risk after the US Supreme Court rejected their appeal, Bloomberg reported Monday, citing a court order. The high court rejected the companies' argument that the lawsuit should...
Form 8.3
Form 8.3
Mar 23, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3
Form 8.3
Mar 23, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Copyright 2023-2026 - www.financetom.com All Rights Reserved